PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Health and Environmental Sciences Institute, Washington, DC, USA.\', \'Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.\', \'SAS Bayer Crop Science, Sophia Antipolis, France.\', \'Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), CNRS, Université Côte d\'Azur, Valbonne, France.\', \'National Institute of Health Sciences, Kanagawa, Japan.\', \'Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.\', \'Office of Research and Development, Environmental Protection Agency, Research Triangle Park, NC, USA.\', \'Division of Immunobiology, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/emmm.202012634
?:doi
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 32375201
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
?:title
  • \'All In\': a pragmatic framework for COVID-19 testing and action on a global scale.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32375201>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32375201>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all